Your browser doesn't support javascript.
loading
Predictive factors of long-term follow-up attendance in very long-term childhood cancer survivors.
Dumas, Agnes; Milcent, Karen; Bougas, Nicolas; Bejarano-Quisoboni, Daniel; El Fayech, Chiraz; Charreire, Hélène; Oberlin, Odile; Patte, Catherine; Allard, Julie; Thebault, Eric; Boumaraf, Amel; Belhout, Amel; Giao, Vu-Bezin; Souchard, Vincent; Jackson, Angela; Allodji, Rodrigue; Valteau-Couanet, Dominique; Dufour, Christelle; Vassal, Gilles; Haddy, Nadia; De Vathaire, Florent; Fresneau, Brice.
  • Dumas A; Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France.
  • Milcent K; Pediatric Department, AP-HP, Antoine Béclère Hospital, Université Paris-Saclay, Clamart, France.
  • Bougas N; Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France.
  • Bejarano-Quisoboni D; INSERM Radiation Epidemiology Team, Villejuif, France.
  • El Fayech C; Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Charreire H; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, Villejuif, France.
  • Oberlin O; Department of Children and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Patte C; LabUrba, Université Paris Est Créteil (UPEC), Créteil, France.
  • Allard J; Institut Universitaire de France (IUF), Paris, France.
  • Thebault E; Department of Children and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Boumaraf A; Department of Children and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Belhout A; Department of Children and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Giao VB; Department of Children and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Souchard V; INSERM Radiation Epidemiology Team, Villejuif, France.
  • Jackson A; Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Allodji R; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, Villejuif, France.
  • Valteau-Couanet D; INSERM Radiation Epidemiology Team, Villejuif, France.
  • Dufour C; Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Vassal G; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, Villejuif, France.
  • Haddy N; INSERM Radiation Epidemiology Team, Villejuif, France.
  • De Vathaire F; Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Fresneau B; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, Villejuif, France.
Cancer ; 129(21): 3476-3489, 2023 Nov 01.
Article en En | MEDLINE | ID: mdl-37432135
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article